Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress.
about
Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic ReviewRed Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia.Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal diseasePathological aspects of lipid peroxidation.The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patientsCirculating growth arrest-specific protein 6 levels are associated with erythropoietin resistance in hemodialysis patients.Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients.Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients.2. Inflammation, Cytokines and Chemokines in Chronic Kidney Disease.Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patientsFactors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study.How can genetics and epigenetics help the nephrologist improve the diagnosis and treatment of chronic kidney disease patients?Erythropoietin and Soluble Erythropoietin Receptor: A Role for Maternal Vascular Adaptation to High-Altitude Pregnancy.Erythropoietin in the critically ill: do we ask the right questions?Some aspects of the anemia of chronic disorders modeled and analyzed by petri net based approach.Effect of iron sucrose on human peritoneal mesothelial cells.Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury.Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study.Serum CRP levels in pre-dialysis patients.Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.The association of red blood cell counts with endothelin-1 in African and Caucasian women.Risk factors for high erythropoiesis stimulating agent resistance index in pre-dialysis chronic kidney disease patients, stages 4 and 5.Effect of protein-energy malnutrition on erythropoietin requirement in maintenance hemodialysis patients.Evaluation of oxidative stress in the anemia of dogs with chronic kidney disease.
P2860
Q26738784-A0CF5718-CCA0-4C6F-BE8B-D17A1FDE395CQ30275352-43E43496-49E6-4934-B385-79BFEA6A99E8Q33532601-0A3C7FC0-8FEB-40A5-84AF-FFF68182CBA0Q34137628-822C61AB-F484-482C-BD6D-4E5C635CFB43Q34515472-D6275419-AA66-4D8B-AE95-B52549B5808EQ36456252-1ED329C8-5837-44E2-8461-83FC7BE8B4F8Q36736661-11287A6B-B377-4DDB-9864-F207F3F8AA71Q37000223-6ECE5030-B553-43C7-856A-5A3F1BC42C7AQ37155228-60ADAB46-0F22-466D-9E73-3E39A162AEB3Q37214510-C823965A-9CDF-4D23-92A5-7574F1148BB0Q37257340-CA4FA26B-8A14-4757-A997-BD73C6A92B20Q38191126-B5414D00-95E6-408E-BE32-D22CB9B2788DQ40491658-4E524344-010E-4E34-97FC-06370B20E355Q42154729-8A05995E-7003-45DB-8D38-97D03452E8BDQ42732254-9D9C4655-E27C-4EA8-808C-89679E2AA317Q44667839-9AEDB67C-E3DB-49B0-89C1-4C3F248FC94EQ46004329-72872DFB-7B21-44B2-A04B-AA198E407A66Q46141374-16D6E690-4740-41B3-848F-78B56ECCC0C9Q46733498-8E2D7A0E-2876-41E4-A4E6-734BAFF30D06Q50535094-4A90E221-9490-4C6A-995A-CAC5BA24357BQ50620507-5D82AD56-7952-4C9D-BA03-4A37FBA65824Q51552133-3A9B2D6F-2A6A-4B0D-AD1A-053C78DAFF17Q51758225-B6E8306A-DB2F-4D73-8ABF-6F41E86B1B7FQ53660721-5C45B695-F69E-422F-9FED-5CF6D54E6D32
P2860
Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Anaemia, rHuEPO resistance, an ...... ammation and oxidative stress.
@ast
Anaemia, rHuEPO resistance, an ...... ammation and oxidative stress.
@en
Anaemia, rHuEPO resistance, an ...... ammation and oxidative stress.
@nl
type
label
Anaemia, rHuEPO resistance, an ...... ammation and oxidative stress.
@ast
Anaemia, rHuEPO resistance, an ...... ammation and oxidative stress.
@en
Anaemia, rHuEPO resistance, an ...... ammation and oxidative stress.
@nl
prefLabel
Anaemia, rHuEPO resistance, an ...... ammation and oxidative stress.
@ast
Anaemia, rHuEPO resistance, an ...... ammation and oxidative stress.
@en
Anaemia, rHuEPO resistance, an ...... ammation and oxidative stress.
@nl
P356
P1476
Anaemia, rHuEPO resistance, an ...... ammation and oxidative stress.
@en
P2093
Peter Bárány
P356
10.1093/NDT/17.SUPPL_5.32
P407
P478
17 Suppl 5
P577
2002-01-01T00:00:00Z